Guger M, Enzinger C, Leutmezer F, Di Pauli F, et al. Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry. J Neurol 2021 Apr 22. pii: 10.1007/s00415-021-10559.
PMID: 33890167